HK1101580A1 - Diastereoselective synthesis process for the preapration of imidazole compounds - Google Patents

Diastereoselective synthesis process for the preapration of imidazole compounds

Info

Publication number
HK1101580A1
HK1101580A1 HK07109363.3A HK07109363A HK1101580A1 HK 1101580 A1 HK1101580 A1 HK 1101580A1 HK 07109363 A HK07109363 A HK 07109363A HK 1101580 A1 HK1101580 A1 HK 1101580A1
Authority
HK
Hong Kong
Prior art keywords
methyl
synthesis process
preapration
sub
imidazole compounds
Prior art date
Application number
HK07109363.3A
Other languages
English (en)
Inventor
Walter Ferdinand Maria Filliers
Rudy Laurent Maria Broeckx
Patrick Rene Angibaud
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1101580A1 publication Critical patent/HK1101580A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK07109363.3A 2004-05-03 2007-08-28 Diastereoselective synthesis process for the preapration of imidazole compounds HK1101580A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04076319 2004-05-03
PCT/EP2005/051934 WO2005105784A1 (en) 2004-05-03 2005-04-28 Diastereoselective synthesis process for the preparation of imidazole compounds

Publications (1)

Publication Number Publication Date
HK1101580A1 true HK1101580A1 (en) 2007-10-18

Family

ID=34966069

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109363.3A HK1101580A1 (en) 2004-05-03 2007-08-28 Diastereoselective synthesis process for the preapration of imidazole compounds

Country Status (11)

Country Link
US (1) US7456287B2 (de)
EP (1) EP1751137B1 (de)
JP (1) JP5008554B2 (de)
CN (1) CN100567292C (de)
AT (1) ATE397600T1 (de)
AU (1) AU2005238223B2 (de)
CA (1) CA2563807C (de)
DE (1) DE602005007346D1 (de)
ES (1) ES2308486T3 (de)
HK (1) HK1101580A1 (de)
WO (1) WO2005105784A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3640345T (lt) 2015-08-17 2022-01-10 Kura Oncology, Inc. Vėžiu sergančių pacientų gydymo būdai farneziltransferazės inhibitoriais
JP2019534290A (ja) 2016-11-03 2019-11-28 クラ オンコロジー， インコーポレイテッド 癌の治療方法において使用するためのファルネシルトランスフェラーゼ阻害剤
US10954210B2 (en) 2016-12-08 2021-03-23 Hangzhou Solipharma Co., Ltd. Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
MX2020012305A (es) 2018-05-18 2021-03-25 Kura Oncology Inc Sintesis de tipifarnib.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037350A (en) * 1995-12-08 2000-03-14 Janssen Pharmaceutica, N.V. Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
HN2000000266A (es) * 2000-01-21 2001-05-21 Pfizer Prod Inc Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
CN1246318C (zh) 2001-03-12 2006-03-22 詹森药业有限公司 咪唑化合物的制备方法
US7408084B2 (en) * 2002-06-11 2008-08-05 Kaneka Corporation Process for producing optically active β-amino alcohol

Also Published As

Publication number Publication date
DE602005007346D1 (de) 2008-07-17
AU2005238223A1 (en) 2005-11-10
EP1751137A1 (de) 2007-02-14
AU2005238223B2 (en) 2012-04-26
US20070238880A1 (en) 2007-10-11
US7456287B2 (en) 2008-11-25
WO2005105784A1 (en) 2005-11-10
CN1946711A (zh) 2007-04-11
CN100567292C (zh) 2009-12-09
CA2563807C (en) 2012-11-20
ES2308486T3 (es) 2008-12-01
EP1751137B1 (de) 2008-06-04
CA2563807A1 (en) 2005-11-10
JP5008554B2 (ja) 2012-08-22
ATE397600T1 (de) 2008-06-15
JP2007536335A (ja) 2007-12-13

Similar Documents

Publication Publication Date Title
DK1713475T3 (da) 1,3,5-trisubstituerede 4,5-dihydro-1H-pyrazol-derivater med CB1-antagonistisk aktivitet
RS54030B1 (en) PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT
WO2008065626A3 (en) 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors
WO2005070890A3 (en) Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
NZ591449A (en) Picolinamide derivatives as kinase inhibitors
GEP20115171B (en) Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
MX2008016423A (es) Arilamidas sustituidas con tetrazol.
PL1651040T3 (pl) Grzybobójcze trójskładnikowe kompozycje substancji czynnych
WO2010131922A4 (en) Amide compound, preparation method thereof and pharmaceutical composition comprising same
CA2683059A1 (en) Atropisomer of pyrrole derivative
WO2008096231A8 (en) Antiparasitic agents
WO2008126901A1 (ja) 含窒素複素環化合物およびそれを含有する医薬組成物
WO2008032338A3 (en) Improved process for the preparation of ezetimibe and its intermediates
HK1101580A1 (en) Diastereoselective synthesis process for the preapration of imidazole compounds
NZ600266A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
EA201100696A1 (ru) 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6
WO2006023659A3 (en) Novel polymorphs of azabicyclohexane
HRP20030695B1 (en) Process for the preparation of imidazole compounds
JP2017502063A5 (de)
MX2012001799A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3).
HK1101326A1 (en) Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
WO2006023395A3 (en) 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors
HK1101398A1 (en) Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline
MX2010002585A (es) Derivados de piperidina como antagonistas del receptor nk3.
MX2007012386A (es) 7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacterianos.